

The Stakes at Deus Ex Medicina
20 snips Sep 5, 2025
Nayeema Raza, a journalist and host of Smart Girl, Dumb Questions, teams up with Eric Newcomer to discuss their upcoming AI health summit, Deus Ex Medicina. They tackle how longevity has gone mainstream, the real impact of precision medicine, and the intriguing question of who controls patient data. The duo dives into D.C. policy shifts affecting healthcare, the potential of AI to discover new drugs, and their excitement for live discussions at the summit, hinting at the convergence of technology and healthcare.
AI Snips
Chapters
Transcript
Episode notes
How Deus Ex Medicina Was Born
- Nayeema and Eric met via mutual industry events and decided to collaborate on an AI-health conference because they both love hosting live events.
- They combined Eric's event infrastructure with Nayeema's editorial and stage skills to build Deus Ex Medicina on Sept 9 in San Francisco.
GLP-1s Propelled Longevity Mainstream
- The GLP-1 moment made longevity culturally and commercially visible to mainstream healthcare and consumers.
- That visibility forces companies and investors to treat longevity as a clear market opportunity, not fringe science.
The N-of-One Future Of Medicine
- Medicine is moving toward individualized care driven by genetic, biometric, and personal data.
- N-of-1 therapies and targeted biologics promise treatments tailored to each person's molecular profile.